← All trials
NCT00000142
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 1994
- Primary completion
- Feb 1, 1996
- Completion date
- Feb 1, 1996
- First posted
- —
- Last posted
- —
- Enrollment
- 64
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Johns Hopkins UniversityLead sponsor
- Baylor UniversityCollaborator
- Rutgers UniversityCollaborator
- Johns Hopkins UniversityCollaborator
- Northwestern UniversityCollaborator
- University of California, Los AngelesCollaborator
- University of California, San DiegoCollaborator
- University of California, San FranciscoCollaborator
- University of MiamiCollaborator
- University of South FloridaCollaborator
- New York UniversityCollaborator
- University of North Carolina at Chapel HillCollaborator
- Louisiana State UniversityCollaborator
- Icahn School of Medicine at Mount SinaiStudy chair
- Icahn School of Medicine at Mount SinaiCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.